Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 32,615 | 597,599 | 340,660 | 948,581 | -295,697 |
| Depreciation Amortization | 89,248 | 82,660 | 67,855 | 57,844 | 51,807 |
| Income taxes - deferred | -85,553 | -158,898 | 57,091 | -465,604 | -350 |
| Accounts receivable | -111,586 | -98,678 | -28,579 | -134,306 | -173,185 |
| Accounts payable and accrued liabilities | 88,159 | -167,945 | 105,436 | 73,343 | 15,120 |
| Other Working Capital | 138,244 | -248,651 | 198,810 | -14,569 | -71,741 |
| Other Operating Activity | 184,210 | 490,400 | 228,668 | 284,199 | 349,447 |
| Operating Cash Flow | $335,337 | $496,487 | $969,941 | $749,488 | $-124,599 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -27,101 | -150,236 | -709 | -3,656 | -3,404 |
| PPE Investments | -86,263 | -32,486 | -77,833 | -181,006 | -187,379 |
| Purchase Of Investment | 0 | -10,000 | 0 | -33,510 | -95,468 |
| Sale Of Investment | 284,781 | 45 | 0 | 10,473 | 17,250 |
| Purchase Sale Intangibles | -13,900 | -15,000 | 0 | 0 | N/A |
| Other Investing Activity | -13,900 | -15,000 | 0 | 0 | 0 |
| Investing Cash Flow | $157,517 | $-207,677 | $-78,542 | $-207,699 | $-269,001 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,798 | -3,360 | -2,862 | -2,417 | -836 |
| Common Stock Issued | 49,301 | 35,836 | 61,115 | 58,626 | 133,064 |
| Common Stock Repurchased | -2,004,790 | 0 | 0 | N/A | N/A |
| Other Financing Activity | -62,260 | -52,509 | -59,047 | -50,033 | -60,519 |
| Financing Cash Flow | $-2,021,547 | $-20,033 | $-794 | $6,176 | $71,709 |
| Exchange Rate Effect | 2,923 | -6,676 | 3,355 | -3,570 | 2,949 |
| Beginning Cash Position | 3,215,221 | 2,953,120 | 2,059,160 | 1,514,765 | 1,833,707 |
| End Cash Position | 1,689,451 | 3,215,221 | 2,953,120 | 2,059,160 | 1,514,765 |
| Net Cash Flow | $-1,525,770 | $262,101 | $893,960 | $544,395 | $-318,942 |
| Free Cash Flow | |||||
| Operating Cash Flow | 335,337 | 496,487 | 969,941 | 749,488 | -124,599 |
| Capital Expenditure | -86,263 | -32,486 | -77,833 | -181,006 | -187,379 |
| Free Cash Flow | 249,074 | 464,001 | 892,108 | 568,482 | -311,978 |